Monday, 21 January, 2019

Valeant Pharmaceuticals International, Inc. (VRX) Given Average Recommendation of "Hold" by Analysts

Valeant Pharmaceuticals International, Inc. (VRX) Given Average Recommendation of Valeant Pharmaceuticals International, Inc. (VRX) Given Average Recommendation of "Hold" by Analysts
Nellie Chapman | 28 June, 2017, 03:30

The Simple Moving Average is potentially the most popular technical analysis tool used by traders. (NASDAQ:SSNC) has risen 26.42% since June 27, 2016 and is uptrending. It has outperformed by 59.56% the S&P500.The move comes after 8 months positive chart setup for the $966.22M company. Riverpark Advsrs Ltd Liability Com reported 14,995 shares. On Tuesday, June 21 the stock rating was downgraded by JP Morgan to "Neutral". Fosun International Ltd acquired 1.55 million shares as Valeant Pharmaceuticals Intl (VRX)'s stock declined 15.71%. Valeant Pharmaceuticals Intl now has $5.99 billion valuation. About shares traded. Werner Enterprises, Inc.

Marathon Trading Investment Management Llc increased Valeant Pharmaceuticals Intl (VRX) stake by 560.13% reported in 2016Q4 SEC filing. It has underperformed by 65.21% the S&P500.

The current share price of the company is trading -47.84% below its 52-week high price of $32.74 and +105.51% higher than 52-week low price of $8.31.

Several analysts have issued reports on the stock. The stock has "Neutral" rating by BTIG Research on Thursday, May 11.

Analyst's mean target price for stock is n/a while analysts mean suggestion is 3.00. The rating was maintained by Jefferies with "Buy" on Monday, November 2. As per Monday, January 11, the company rating was downgraded by Morgan Stanley.

Investors sentiment increased to 1.39 in Q4 2016. Its down 0.03, from 1.18 in 2016Q3.

ATR remains at 0.81 while Beta component of the stock stands at -0.31. Bnp Paribas Investment Partners Sa invested 0.03% of its portfolio in Newell Brands Inc (NYSE:NWL). Paloma Ptnrs Management reported 175,879 shares stake. Krasney Financial Limited Liability owns 29,775 shares. Credit Suisse Ag holds 0.01% or 925,687 shares. (NASDAQ:SSNC). Mirae Asset Glob Invests has 0.05% invested in SS&C Technologies Holdings, Inc. It also reduced Citrix Sys Inc (NASDAQ:CTXS) stake by 39,900 shares and now owns 64,800 shares. Rock Springs Mngmt Ltd Partnership reported 71,400 shares or 0.07% of all its holdings. Great Lakes Advsr invested in 174,163 shares.

Exactech, Inc. (NASDAQ:EXAC) announced that the company marked the first clinical use of recently approved shoulder, knee and hip replacement systems in Japan this quarter. The company has market cap of $602.61 million. If earnings are expected to grow in the future, the estimated P/E will be lower than the current P/E. The Company's geographic divisions include United States and Europe.

Since March 13, 2017, it had 3 insider buys, and 1 insider sale for $166.26 million activity.

New York-based hedge fund Paulson & Co on Monday reported a 6.3 per cent stake in embattled Canadian drugmaker Valeant Pharmaceuticals International Inc.

Turning to earnings, analysts are expecting Valeant Pharmaceuticals International, Inc.

In other news, Director Schutter Richard U. De purchased 20,000 shares of the stock in a transaction dated Thursday, May 11th. Its down 0.31, from 1.12 in 2016Q3. It dived, as 82 investors sold VRX shares while 87 reduced holdings. WFG Advisors LP raised its position in Valeant Pharmaceuticals International by 302.5% in the fourth quarter.

Shares outstanding are recorded as 14.10 million and total shares floated are 10.61 million. Hexavest invested in 264,677 shares. Thompson Davis And Company Incorporated reported 276 shares stake. Toronto Dominion Fincl Bank owns 7.55M shares.

The share price of the company (NYSE:VRX) was up +8.10%, with a high of 17.44 during the day and the volume of Valeant Pharmaceuticals International, Inc. shares traded was 26885. Brown Brothers Harriman accumulated 1,000 shares. Ladenburg Thalmann Financial Services Inc. raised its position in Valeant Pharmaceuticals International by 26.4% in the fourth quarter. Northwestern Mutual Wealth reported 38,181 shares. 423.47 million shares or 3.26% less from 437.73 million shares in 2016Q3 were reported. 42,000 were accumulated by Quantitative Investment Llc. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has declined 48.51% since June 26, 2016 and is downtrending. State Of Wisconsin Inv Board holds 0.01% or 91,849 shares. Moreover, Bank Of America De has 0.01% invested in Valeant Pharmaceuticals Intl Inc (TSE:VRX) for 4.58M shares. Return on Equity for Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is -34.10%.

Among 25 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 6 have Buy rating, 3 Sell and 16 Hold. Therefore 88% are positive. Newell Rubbermaid Inc. had 23 analyst reports since August 4, 2015 according to SRatingsIntel. The firm earned "Outperform" rating on Thursday, October 27 by Macquarie Research.

Valeant Pharmaceuticals International (VRX) traded down 1.23% during midday trading on Tuesday, reaching $16.87. (NYSE:VRX) (TSE:VRX)'s stock had its "sell" rating restated by analysts at Wells Fargo & Company in a research report issued on Tuesday. The firm has "Hold" rating given on Wednesday, July 20 by TD Securities. Currently Valeant Pharmaceuticals International, Inc. The stock rose 2.53% or $0.4 reaching $16.2. The company was initiated on Tuesday, September 20 by Deutsche Bank.

News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals International, Inc. with's FREE daily email newsletter.